(Q34087862)

30 July 2017

1 reference

title

Brain tumors in the older person (English)

1 reference

30 July 2017

1 reference

Flowers A

1

1 reference

30 July 2017

publication date

1 November 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

7

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

523-538

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

30 July 2017

1 reference

21 January 2018

Cancer statistics, 1991.

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Increasing annual incidence of primary malignant brain tumors in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Is brain cancer mortality increasing in industrial countries?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

The trends in incidence of primary brain tumors in the population of Rochester, Minnesota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Brain tumors in the elderly: recent trends in a Minnesota cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Time Trends in Incidence of Brain and Central Nervous System Cancers in Connecticut

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Descriptive epidemiology of cerebral gliomas in France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Incidence of primary cancer of the central nervous system in southeastern Netherlands during the period 1980-94. Specialists in neuro-oncology in southeastern Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Increasing incidence of primary malignant brain tumors: influence of diagnostic methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Increased mortality from brain tumors: a combined outcome of diagnostic technology and change of attitude toward the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

The age curve of nervous system tumour incidence in adults: common shape but changing levels by sex, race and geographical location

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Is the increased incidence of primary malignant brain tumors in the elderly real?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Rising primary malignant brain tumor mortality in the elderly. A manifestation of differential survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Brain tumors and the geriatric patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Astrocytoma risk related to job exposure to electric and magnetic fields

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Nervous system neoplasms and primary malignancies of other sites. The unique association between meningiomas and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Association of malignant brain tumors and cancers of other sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Patient age, histologic features, and length of survival in patients with glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Report of a workshop sponsored by the European Organisation for Research and Treatment of Cancer (EORTC) on the treatment of primary malignant brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

21 January 2018

Brain tumors. Part 1.

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Do surgical brain lesions present as isolated dementia? A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Perfusion and metabolism in predicting the survival of patients with cerebral gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Correlation of thallium-201 single photon emission computed tomography and survival after treatment failure in patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Grading of astrocytomas. A simple and reproducible method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Correlates of survival and the Daumas-Duport grading system for astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Survival and prognosis of patients with astrocytoma with atypical or anaplastic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Mixed oligoastrocytomas: a survival and prognostic factor analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Prognostic scoring in adult astrocytic tumors using patient age, histopathological grade, and DNA histogram type

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

MIB-1 proliferation index predicts survival among patients with grade II astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Prognostic implications of p53 overexpression in supratentorial astrocytic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Supratentorial low-grade astrocytomas in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Effect of age on treatment decisions in low-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Do elderly patients overutilize healthcare resources and benefit less from them than younger patients? A study of patients who underwent craniotomy for treatment of neoplasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Brain Tumors in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Brain tumor surgery in geriatric patients: a critical analysis in 44 patients over 80 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Effect of Age and Reoperation on Survival in the Combined Modality Treatment of Malignant Astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Radiation therapy of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Low-grade gliomas: to treat or not to treat? A radiation oncologist's viewpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Malignant supratentorial glioma in the elderly: is radiotherapy useful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

The effect of advanced age on the efficacy of radiation therapy for early breast cancer, local prostate cancer and grade III-IV gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Supratentorial malignant glioma: an analysis of radiation therapy in 178 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Efficacy of radiotherapy for malignant gliomas in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Hypofractionated radiation therapy and concurrent cisplatin in malignant cerebral gliomas. Rapid palliation in low performance status patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Accelerated fractionation radiotherapy for hospitalized glioblastoma multiforme patients with poor prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Fractionated stereotactic radiation therapy for intracranial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Survival following interstitial brachytherapy for recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Intralesional radioimmunotherapy of malignant gliomas. An effective treatment in recurrent tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Radiation effects on cerebral white matter: MR evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Biphasic patterns of memory deficits following moderate-dose partial-brain irradiation: neuropsychologic outcome and proposed mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Resistance to cytostatic drugs at the cellular level

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Do anticancer agents reach the tumor target in the human brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Alternating sequential intracarotid BCNU and cisplatin in recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Procarbazine chemotherapy in the treatment of recurrent malignant astrocytomas after radiation and nitrosourea failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Comparison between BCNU and procarbazine chemotherapy for treatment of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Low-grade oligodendroglioma responds to chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Pre-radiation chemotherapy in glioma patients with poor prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Cytokines and immunoregulatory molecules in malignant glial neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Clinical effect of interferon in malignant brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Phase II trial of interferon-beta for treatment of recurrent glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

A pilot study of recombinant interferon beta (IFN-beta ser) in patients with recurrent glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Reversible osmotic blood-brain barrier disruption in humans: implications for the chemotherapy of malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Osmotic blood-brain barrier disruption and chemotherapy in the treatment of high grade malignant glioma: patient series and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Expanded spectrum of viral therapy in the treatment of nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Immunotoxins and central nervous system neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Improved tumor-specific immunotoxins in the treatment of CNS and leptomeningeal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Age influences chemotherapy response in astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Quality of survival of patients with brain gliomas treated with postoperative CCNU and radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

Cancer control and the older person. Issues in treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480000700604

10.1177/107327480000700604

21 January 2018

Identifiers

DOI

0 references

1 reference